ALKERMES PLC (ALKS)       25.27  +0.27 (+1.08%)

25.27  +0.27 (+1.08%)

IE00B56GVS15 - Common Stock - After market: 25.27 0 (0%)

ALKERMES PLC25.27

NASDAQ:ALKS (12/7/2022, 7:22:58 PM)+0.27 (+1.08%)

After market: 25.27 0 (0%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Biotechnology
Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend
Overview
Earnings (Last) 11-02 2022-11-02/bmo Earnings (Next) N/A N/A
Ins Owners 1.1% Inst Owners 97.66%
Market Cap 4.15B Shares 164.31M
PE 58.77 Fwd PE 55.05
Dividend Yield N/A Analysts 76.25
IPO 07-16 1991-07-16

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ALKS Daily chart

Company Profile

Alkermes Plc is a global biopharmaceutical company. The company is headquartered in Dublin, Dublin and currently employs 2,211 full-time employees. The firm is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The company has a portfolio of commercial products focused on addiction, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. The firm's products include ALKERMES, ARISTADA, ARISTADA INITIO, LinkeRx, LYBALVI, NanoCrystal and VIVITROL. Its other trademark includes INVEGA SUSTENNA, INVEGA TRINZA, TREVICTA, XEPLION, and RISPERDAL CONSTA, KEYTRUDA and VUMERITY. The firm's product platforms include injectable extended-release microsphere technology, LinkeRx technology, NanoCrystal technology and oral controlled release (OCR) technology. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia.

Company Info

ALKERMES PLC

Connaught HSE, 1 Burlington Road

DUBLIN DUBLIN DUBLIN 4

P: 35317728000.0

CEO: Richard F. Pops

Employees: 2211

Website: http://www.alkermes.com/

ALKS News

News Image2 days ago - Market News VideoNotable Tuesday Option Activity: ALKS, GFF, OLEDNews Image6 days ago - Market News VideoBullish Two Hundred Day Moving Average Cross - ALKSNews Image8 days ago - Alkermes plcAlkermes to Participate in the BofA Securities 2022 Biotech SMID Cap Conference

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat as part of the BofA Securities 2022 Biotech...

News Image16 days ago - Alkermes plcAlkermes to Participate in the 5th Annual Evercore ISI HealthCONx Conference

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the 5th Annual Evercore ISI HealthCONx...

News Imagea month ago - Alkermes plcAlkermes to Participate in the Stifel Healthcare Conference

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Stifel 2022 Healthcare Conference on...

News Imagea month ago - Market News VideoAlkermes Larger Than S&P 500 Component DISH Network

ALKS Twits

Here you can normally see the latest stock twits on ALKS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example